Kosuke Takigawa

Molecular diagnosis of diffuse glioma using a chip-based digital PCR system to analyze IDH, TERT, and H3 mutations in the cerebrospinal fluid

Yutaka Fujioka, Nobuhiro Hata, Yojiro Akagi et al. · Journal of Neuro-Oncology · 2021 · 45 citations · Full text

Clinical significance of <i>CDKN2A</i> homozygous deletion in combination with methylated <i>MGMT</i> status for <i>IDH</i>‐wildtype glioblastoma

Yusuke Funakoshi, Nobuhiro Hata, Kosuke Takigawa et al. · Cancer Medicine · 2021 · 33 citations · Full text

CD206 Expression in Induced Microglia-Like Cells From Peripheral Blood as a Surrogate Biomarker for the Specific Immune Microenvironment of Neurosurgical Diseases Including Glioma

Shunya Tanaka, Masahiro Ohgidani, Nobuhiro Hata et al. · Frontiers in Immunology · 2021 · 29 citations · Full text

First-line bevacizumab contributes to survival improvement in glioblastoma patients complementary to temozolomide

Nobuhiro Hata, Masahiro Mizoguchi, Daisuke Kuga et al. · Journal of Neuro-Oncology · 2020 · 22 citations

Neuro-oncology, Oncology, First-line Bevacizumab Contributes +10

Mesenchymal glioblastoma-induced mature de-novo vessel formation of vascular endothelial cells in a microfluidic device

Takeo Amemiya, Nobuhiro Hata, Masahiro Mizoguchi et al. · Molecular Biology Reports · 2021 · 19 citations · Full text